NMDP Hires New Leaders to Executive Team to Continue Advancing Five-Year Strategic Plan
June 21 2024 - 9:00AM
Business Wire
New Chief Financial and Chief Information
Officers to Extend Global Cell Therapy Nonprofit’s Operational
Excellence in its Quest to Find More Cures and Save More Lives
NMDPSM, a global nonprofit leader in cell
therapy, announced today it hired two new executives – Katherine
Heyerdahl as chief financial officer (CFO) and Jim Graham as chief
information officer (CIO) – to its executive team, where they will
play pivotal roles in driving the organization’s mission-critical
operational strategy. Heyerdahl and Graham are filling existing
executive leadership roles.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240621400378/en/
Katherine Heyerdahl, chief financial
officer, NMDP (Photo: Business Wire)
“We have an ambitious, bold vision to accelerate our global
impact in the next five years and impact 10,000 lives annually via
life-saving stem cell therapy,” said Amy Ronneberg, CEO of NMDP.
“Ensuring every patient with blood cancers and disorders has access
to the life-saving cell therapy they deserve requires a proven
leadership team relentlessly focused on operational excellence and
execution.”
Graham will join the organization on July 8 and will lead all
aspects of information technology, including modernizing and
scaling platforms and maintaining system security, automation and
operational efficiencies. Most recently, he spent 11 years at Prime
Therapeutics, a Twin Cities-based pharmacy benefit management
company. As CIO, he led a multi-year initiative to modernize and
scale technology platforms during a new operating model
implementation, which helped improve speed-to-market,
state-of-the-art automation, and access to information. Before
Prime, Graham spent over a decade in executive IT roles at Voya
Financial, formerly ING.
Heyerdahl joined NMDP April 22, spearheading the organization’s
financial sustainability – one of NMDP’s key operating metrics – as
well as on pricing for its products and services. She most recently
served as chief strategy officer for the Individual and Family
Plans business at UnitedHealth Group (UHG), where she delivered on
a new market expansion strategy, long-term business plan and
capital portfolio for UHG’s Healthcare Exchange business.
Previously, she held various leadership roles within the Optum
segment of UHG, The Travelers Companies and Deloitte &
Touche.
“Katherine and Jim are stepping into critical roles, with NMDP
at the precipice of unparalleled growth. They not only bring deep
healthcare expertise to our bench of talent, they are also
respected as mission-driven, operational leaders and experienced
stewards of the resources needed to advance cell therapy research,
deliver best-in-class service and expand equitable access to
life-saving cell therapy,” Ronneberg added. “We’re thrilled they
are joining us to help find more cures and save more lives.”
About NMDPSM
At NMDPSM, we believe each of us holds the key to curing blood
cancers and disorders. As a global nonprofit leader in cell
therapy, NMDP creates essential connections between researchers and
supporters to inspire action and accelerate innovation to find
life-saving cures. With the help of blood stem cell donors from the
world’s most diverse registry and our extensive network of
transplant partners, physicians and caregivers, we’re expanding
access to treatment so that every patient can receive their
life-saving cell therapy. NMDP. Find cures. Save lives.
Learn more at nmdp.org.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240621400378/en/
Jess Ayers media@nmdp.org